Cited by 122Nanoparticle-Based Drug DeliveryBarrier Structure and Function StudiesRNA Interference and Gene Delivery

Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging

Open access
Han, Liang, Kong, Derek K., Zheng, Ming-qiang, Murikinati, Sasidhar, Ma, Chao, Yuan, Peng, Li, Liyuan, Tian, Daofeng +11 more·2016·ACS Nano

Abstract

The blood-brain barrier (BBB) is partially disrupted in brain tumors. Despite the gaps in the BBB, there is an inadequate amount of pharmacological agents delivered into the brain. Thus, the low delivery efficiency renders many of these agents ineffective in treating brain cancer. In this report, we proposed an "autocatalytic" approach for increasing the transport of nanoparticles into the brain. In this strategy, a small number of nanoparticles enter into the brain via transcytosis or through the BBB gaps. After penetrating the BBB, the nanoparticles release BBB modulators, which enables more nanoparticles to be transported, creating a positive feedback loop for increased delivery. Specifically, we demonstrated that these autocatalytic brain tumor-targeting poly(amine-co-ester) terpolymer nanoparticles (ABTT NPs) can readily cross the BBB and preferentially accumulate in brain tumors at a concentration of 4.3- and 94.0-fold greater than that in the liver and in brain regions without tumors, respectively. We further demonstrated that ABTT NPs were capable of mediating brain cancer gene therapy and chemotherapy. Our results suggest ABTT NPs can prime the brain to increase the systemic delivery of therapeutics for treating brain malignancies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.5b07573

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CTX-mHph2-III-62% nanoparticles co-encapsulating minoxidil, lexiscan, and NECA can release blood-brain barrier modulators in the local tumor site, adjusting paracellular permeability to ensure more nanoparticles in the same area.

    “Through co-encapsulation, such nanoparticles could release BBB modulators in the local tumor site, which adjust the permeability of BBB in the paracellular pathway to ensure more nanoparticles in the same area.”

    From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [151]

    The Results and Discussion section (page not provided) reports that nanoparticles carrying a BBB modulator increased delivery to mouse brain tumors, and describes changes to tight-junction molecules consistent with altered paracellular permeability. It evaluates minoxidil, Lexiscan, and NECA as alternatives, however, not as three agents co-encapsulated in the same nanoparticles. The Conclusion and Outlook also says the mechanism of Lexiscan’s BBB modulation from the brain side has not been elucidated, so the specific paracellular mechanism is not established for these nanoparticles. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Han, L., Kong, D. K., Zheng, M.-Q., Murikinati, S., Ma, C., Yuan, P., Li, L., Tian, D., Cai, Q., Ye, C., Holden, D., Park, J.-H., Gao, X., Thomas, J.-L., Grutzendler, J., Carson, R. E., Huang, Y., Piepmeier, J. M., & Zhou, J.
Affiliations
  • Yale University (US)
  • Department of Neurosurgery, #Department of Biomedical Engineering, ‡PET Center, Department of Diagnostic Radiology, §Department of Neurology, and ⊥Department of Pathology, Yale University, New Haven, Connecticut 06511, United States
Corresponding author
Zhou, Jiangbing
Venue
ACS Nano
Published
2016-03-16
Volume
10
Issue
4
Pages
4209-4218
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W2294107204
Cited by
122
References
54
Citations by year
2026: 5 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 15 · 2021: 15 · 2020: 25 · 2019: 12 · 2018: 16 · 2017: 7 · 2016: 5
FWCI
5.45
Type
journal article
Language
en
Open access
Locations
  • ACS Nano (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Center for Advancing Translational Sciences (UL1 TR000142)
  • National Institute of Neurological Disorders and Stroke (NS095817)
  • China Scholarship Council
  • Matthew Larson Foundation for Pediatric Brain Tumors
  • State of Connecticut
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
brain tumors, blood-brain barrier, nanoparticle delivery, transcytosis, tumor-targeting nanoparticles, tumor imaging
MeSH terms
Animals, Antineoplastic Agents, Biological Transport, Blood-Brain Barrier, Brain Neoplasms, Decanoic Acids, Ethanolamines, Female, Humans, Mice, Inbred C57BL, Permeability, Polymers, Purines, Pyrazoles, Scorpion Venoms, Genetic Therapy, Drug Delivery Systems, Paclitaxel, Matrix Metalloproteinase 2, Cell Line, Tumor, Mice, Nanoparticles, Transcytosis, Tumor Microenvironment, Optical Imaging, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review